Literature DB >> 17454169

Prevalence of the metabolic syndrome in Asian women with polycystic ovary syndrome: using the International Diabetes Federation criteria.

Sawaek Weerakiet1, Pongamon Bunnag, Bunyong Phakdeekitcharoen, Surapee Wansumrith, Suwannee Chanprasertyothin, Rattiya Jultanmas, Ammarin Thakkinstian.   

Abstract

BACKGROUND: Since insulin resistance and compensatory hyperinsulinemia are the major causes of the metabolic syndrome (MS) and are also the main pathophysiology of polycystic ovary syndrome (PCOS), PCOS women are at risk of MS. The aim of the present cross-sectional study was to determine the prevalence of MS in Asian women with PCOS using the International Diabetes Federation (IDF) criteria and to define the risk factors.
METHODS: One hundred and seventy women with PCOS were enrolled in the study from September 3, 2002 to June 14, 2005. A 75-g oral glucose tolerance test with plasma glucose and serum insulin levels was performed. Also, blood samples were examined for fasting triglycerides, high-density lipoprotein cholesterol and adiponectin levels.
RESULTS: The mean (+/-standard deviation) age, body mass index (BMI) and waist-to-hip ratio were 28.8+/-5.9 years, 27.1 +/- 7.0 kg/m(2) and 0.85+/-0.06, respectively. The prevalence of MS was 35.3%. Age, BMI, waist circumference and all metabolic parameters were higher in PCOS women with MS than in those without MS. MS prevalence increased with age, BMI and insulin resistance as determined by homeostasis model assessment (HOMA-IR), but not with adiponectin after BMI adjustment.
CONCLUSIONS: According to the IDF criteria, one-third of the PCOS women had MS. This study also showed that age, BMI and HOMA-IR are important risk factors for MS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17454169     DOI: 10.1080/09513590701214158

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  12 in total

Review 1.  Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.

Authors:  Lara C Morley; Thomas Tang; Ephia Yasmin; Robert J Norman; Adam H Balen
Journal:  Cochrane Database Syst Rev       Date:  2017-11-29

Review 2.  Adiponectin action from head to toe.

Authors:  Karine Brochu-Gaudreau; Charlotte Rehfeldt; Richard Blouin; V Bordignon; Bruce D Murphy; Marie-France Palin
Journal:  Endocrine       Date:  2009-12-01       Impact factor: 3.633

3.  Novel inflammatory markers in overweight women with and without polycystic ovary syndrome and following pharmacological intervention.

Authors:  L J Moran; C Meyer; S K Hutchison; S Zoungas; H J Teede
Journal:  J Endocrinol Invest       Date:  2009-10-15       Impact factor: 4.256

4.  Polycystic ovary syndrome, body mass index and outcomes of assisted reproductive technologies.

Authors:  Hind A Beydoun; Laurel Stadtmauer; May A Beydoun; Helena Russell; Yueqin Zhao; Sergio Oehninger
Journal:  Reprod Biomed Online       Date:  2009-06       Impact factor: 3.828

5.  Using principal component analysis to develop a single-parameter screening tool for metabolic syndrome.

Authors:  Chia-Hao Chang; Ching-Ho Yen; Mei-Yen Chen
Journal:  BMC Public Health       Date:  2010-11-18       Impact factor: 3.295

6.  Prevalence of metabolic syndrome is higher among non-obese PCOS women with hyperandrogenism and menstrual irregularity in Korea.

Authors:  Min-Ju Kim; Nam-Kyoo Lim; Young-Min Choi; Jin-Ju Kim; Kyu-Ri Hwang; Soo-Jin Chae; Chan-Woo Park; Doo-Seok Choi; Byung-Moon Kang; Byung-Seok Lee; Tak Kim; Hyun-Young Park
Journal:  PLoS One       Date:  2014-06-05       Impact factor: 3.240

7.  Development of Chinese Version of Polycystic Ovary Syndrome Health-Related Quality of Life Questionnaire (Chi-PCOSQ).

Authors:  Huang-tz Ou; Meng-Hsing Wu; Chung-Ying Lin; Pei-Chi Chen
Journal:  PLoS One       Date:  2015-10-09       Impact factor: 3.240

8.  Association between Metabolic Syndrome and Menstrual Irregularity in Middle-Aged Korean Women.

Authors:  Sang Su Lee; Do Hoon Kim; Ga-Eun Nam; Hyo-Yun Nam; Young Eun Kim; Sung Ho Lee; Kyung Do Han; Yong Gyu Park
Journal:  Korean J Fam Med       Date:  2016-01-27

9.  Waist Circumference Coupled with Either HDL-C or TG Can Be Used as a Diagnostic Marker for Metabolic Syndrome in Chinese Women with Polycystic Ovary Syndrome.

Authors:  Yan Sun; Wenxiang Wang; Qi Shen; Shengrong Du; Yiwei Guo; Fei He; Wenchang Zhang
Journal:  Int J Endocrinol       Date:  2018-09-10       Impact factor: 3.257

10.  Comparison of metabolic syndrome elements in White and Asian women with polycystic ovary syndrome: results of a regional, American cross-sectional study.

Authors:  Nikhita Chahal; Molly Quinn; Eleni A Jaswa; Chia-Ning Kao; Marcelle I Cedars; Heather G Huddleston
Journal:  F S Rep       Date:  2020-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.